Works matching IS 00070920 AND DT 2023 AND VI 128 AND IP 8
Results: 21
Genomic ALK alterations in primary and relapsed neuroblastoma.
- Published in:
- British Journal of Cancer, 2023, v. 128, n. 8, p. 1559, doi. 10.1038/s41416-023-02208-y
- By:
- Publication type:
- Article
Clinical outcome and prognostic factors for Asian patients in Phase I clinical trials.
- Published in:
- British Journal of Cancer, 2023, v. 128, n. 8, p. 1514, doi. 10.1038/s41416-023-02193-2
- By:
- Publication type:
- Article
Utility of molecular subtypes and genetic alterations for evaluating clinical outcomes in 1029 patients with endometrial cancer.
- Published in:
- British Journal of Cancer, 2023, v. 128, n. 8, p. 1582, doi. 10.1038/s41416-023-02203-3
- By:
- Publication type:
- Article
Revitalising cancer clinical trials: definitely time for patient-centred reform.
- Published in:
- 2023
- By:
- Publication type:
- Editorial
An antibody–drug conjugate targeting GPR56 demonstrates efficacy in preclinical models of colorectal cancer.
- Published in:
- British Journal of Cancer, 2023, v. 128, n. 8, p. 1592, doi. 10.1038/s41416-023-02192-3
- By:
- Publication type:
- Article
Revitalising cancer trials post-pandemic: time for reform.
- Published in:
- British Journal of Cancer, 2023, v. 128, n. 8, p. 1409, doi. 10.1038/s41416-023-02224-y
- By:
- Publication type:
- Article
Clinical significance of circulating-tumour DNA analysis by metastatic sites in pancreatic cancer.
- Published in:
- British Journal of Cancer, 2023, v. 128, n. 8, p. 1603, doi. 10.1038/s41416-023-02189-y
- By:
- Publication type:
- Article
Immortal-time bias in older vs younger age groups: a simulation study with application to a population-based cohort of patients with colon cancer.
- Published in:
- British Journal of Cancer, 2023, v. 128, n. 8, p. 1521, doi. 10.1038/s41416-023-02187-0
- By:
- Publication type:
- Article
Sec61γ is a vital protein in the endoplasmic reticulum membrane promoting tumor metastasis and invasion in lung adenocarcinoma.
- Published in:
- British Journal of Cancer, 2023, v. 128, n. 8, p. 1478, doi. 10.1038/s41416-023-02150-z
- By:
- Publication type:
- Article
Prevalence of tumour-infiltrating CD103<sup>+</sup> cells identifies therapeutic-sensitive prostate cancer with poor clinical outcome.
- Published in:
- British Journal of Cancer, 2023, v. 128, n. 8, p. 1466, doi. 10.1038/s41416-023-02183-4
- By:
- Publication type:
- Article
Sodium-glucose cotransporter 2 (SGLT2) inhibitors and non-small cell lung cancer survival.
- Published in:
- British Journal of Cancer, 2023, v. 128, n. 8, p. 1541, doi. 10.1038/s41416-023-02177-2
- By:
- Publication type:
- Article
Tumour-educated platelets for breast cancer detection: biological and technical insights.
- Published in:
- British Journal of Cancer, 2023, v. 128, n. 8, p. 1572, doi. 10.1038/s41416-023-02174-5
- By:
- Publication type:
- Article
Dietary intake of total, heme and non-heme iron and the risk of colorectal cancer in a European prospective cohort study.
- Published in:
- British Journal of Cancer, 2023, v. 128, n. 8, p. 1529, doi. 10.1038/s41416-023-02164-7
- By:
- Publication type:
- Article
Psychological impact of risk-stratified screening as part of the NHS Breast Screening Programme: multi-site non-randomised comparison of BC-Predict versus usual screening (NCT04359420).
- Published in:
- British Journal of Cancer, 2023, v. 128, n. 8, p. 1548, doi. 10.1038/s41416-023-02156-7
- By:
- Publication type:
- Article
Immune checkpoint inhibitor combinations—current and emerging strategies.
- Published in:
- 2023
- By:
- Publication type:
- Editorial
INOVATYON/ ENGOT-ov5 study: Randomized phase III international study comparing trabectedin/pegylated liposomal doxorubicin (PLD) followed by platinum at progression vs carboplatin/PLD in patients with recurrent ovarian cancer progressing within 6-12 months after last platinum line
- Published in:
- British Journal of Cancer, 2023, v. 128, n. 8, p. 1503, doi. 10.1038/s41416-022-02108-7
- By:
- Publication type:
- Article
Ferroptosis in colorectal cancer: a future target?
- Published in:
- British Journal of Cancer, 2023, v. 128, n. 8, p. 1439, doi. 10.1038/s41416-023-02149-6
- By:
- Publication type:
- Article
A Phase 1/2 study of the PD-L1 inhibitor, BGB-A333, alone and in combination with the PD-1 inhibitor, tislelizumab, in patients with advanced solid tumours.
- Published in:
- British Journal of Cancer, 2023, v. 128, n. 8, p. 1418, doi. 10.1038/s41416-022-02128-3
- By:
- Publication type:
- Article
AMPK phosphorylates and stabilises copper transporter 1 to synergise metformin and copper chelator for breast cancer therapy.
- Published in:
- British Journal of Cancer, 2023, v. 128, n. 8, p. 1452, doi. 10.1038/s41416-022-02127-4
- By:
- Publication type:
- Article
The 'stealth-bomber' paradigm for deciphering the tumour response to carbon-ion irradiation.
- Published in:
- British Journal of Cancer, 2023, v. 128, n. 8, p. 1429, doi. 10.1038/s41416-022-02117-6
- By:
- Publication type:
- Article
Manassantin A inhibits tumour growth under hypoxia through the activation of chaperone-mediated autophagy by modulating Hsp90 activity.
- Published in:
- British Journal of Cancer, 2023, v. 128, n. 8, p. 1491, doi. 10.1038/s41416-023-02148-7
- By:
- Publication type:
- Article